(Total Views: 512)
Posted On: 01/22/2021 12:44:59 PM
Post# of 72444
Common Sense: Based on the new task force guidance and IPIX testing history, I'm almost certain there will be funding for additional preclinical testing of B on 2 things:
1) New Viruses
2) Drug combinations
The guidance talks to therapies in progress for COVID and to future threats. I can't imagine that B won't be tested against lot's of biological agents including more bacteria, fungus, viruses, etc.
Little Speculation:
I have a feeling there is a reason why the phase 2 hasn't started yet. Could there be a reason to wait for the new administration in office? Could they want to expand our trial (increasing n, or several different dosing arms or a combo arm)?.
My thoughts are: it seems silly and risky to just let IPIX do it own small trial without government/BP assistance and to only take action AFTER trial results. If good, I would think IPIX should already have stockpiled additional B and have a BP partner to help with increasing production, distribution, marketing etc.
Wonder what we are going to learn next?
1) New Viruses
2) Drug combinations
The guidance talks to therapies in progress for COVID and to future threats. I can't imagine that B won't be tested against lot's of biological agents including more bacteria, fungus, viruses, etc.
Little Speculation:
I have a feeling there is a reason why the phase 2 hasn't started yet. Could there be a reason to wait for the new administration in office? Could they want to expand our trial (increasing n, or several different dosing arms or a combo arm)?.
My thoughts are: it seems silly and risky to just let IPIX do it own small trial without government/BP assistance and to only take action AFTER trial results. If good, I would think IPIX should already have stockpiled additional B and have a BP partner to help with increasing production, distribution, marketing etc.
Wonder what we are going to learn next?
(5)
(0)
